Form 4: Lilly Endowment Inc. Sells Shares in Eli Lilly & Co.

Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., has sold a portion of its holdings in multiple transactions on June 7, 2024.

Summary

• Lilly Endowment Inc. sold a total of 139,480 shares of Eli Lilly & Co. common stock on June 7, 2024.
• The sales were executed in multiple transactions at varying weighted average prices.
• The prices ranged from $851.291 to $856.384 per share.
• Following these transactions, Lilly Endowment Inc. still holds 97,869,320 shares of Eli Lilly & Co. common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of a share sale, with no indication of positive or negative sentiment.

Industry Context

This filing reflects a routine transaction by a major shareholder and is not indicative of any specific industry trend or competitive shift.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by major shareholders and insiders of publicly traded companies.
• The transaction is similar to other large block trades by institutional investors, which are common in the market.
• The price range of the transactions is consistent with the trading price of Eli Lilly & Co. stock on the date of the sale.

Stakeholder Impact

• The share sale may have a minor impact on the stock price of Eli Lilly & Co., but is unlikely to have a significant effect on other stakeholders.

Key Dates

Keywords

Eli Lilly & Co, Lilly Endowment Inc, share sale, stock transaction, beneficial ownership, SEC Form 4